Business & Finance

Bayer predicts mid-term earnings growth on agriculture, consumer health

  • The agriculture and pharmaceuticals group said in a statement it was aiming for core earnings per share of between 7 euros ($8.3) and 7.50 euros by 2024, up from 6.39 euros in 2020.
Published March 10, 2021 Updated March 10, 2021 06:09pm
By

FRANKFURT: Germany's Bayer on Wednesday pledged to boost adjusted earnings growth until 2024, helped by the launch of digital farming services, soy seeds and consumer health products.

The agriculture and pharmaceuticals group said in a statement it was aiming for core earnings per share of between 7 euros ($8.3) and 7.50 euros by 2024, up from 6.39 euros in 2020.